Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Zeng, X ^a   Li, Y ^a   Fan, J ^a   Zhao, H ^a   Xian, Z ^a   Sun, Y ^a   Wang, Z ^a   Wang, S ^a   Zhang, G ^a   Ju, D ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Non Hodgkin's lymphoma; Recombinant human arginase

Indexed keywords

3 METHYLADENINE; ARGINASE; ARGININE; AUTOPHAGY PROTEIN 5; BECLIN 1; CASPASE; CHLOROQUINE; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3 II; RECOMBINANT HUMAN ARGINASE; S6 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RAJI CELL; SIGNAL TRANSDUCTION;

APOPTOSIS; ARGINASE; ARGININE; AUTOPHAGY; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LYMPHOMA, NON-HODGKIN; RECOMBINANT PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84887468482     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.359     Document Type: Article

References (43)

1. Chow AK, Ng L, Sing LH, Cheng CW, Lam CS, Yau TC et al. Anti-Tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma. Curr Cancer drug tar 2012; 12: 1233-1243.
2. Cheng PN, Lam TL, Lam WM, Tsui SM, Cheng AW, Lo WH et al. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 2007; 67: 309-317.
3. Lam TL, Wong GK, Chong HC, Cheng PN, Choi SC, Chow TL et al. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett 2009; 277: 91-100.
4. Lam TL, Wong GK, Chow HY, Chong HC, Chow TL, Kwok SY et al. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis. Pigm Cell Melanoma R 2011; 24: 366-376.
5. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003; 24: 302-306.
6. Tan B, Yin Y, Kong X, Li P, Li X, Gao H et al. L-Arginine stimulates proliferation and prevents endotoxin-induced death of intestinal cells. Amino Acids 2010; 38: 1227-1235.
7. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009; 37: 153-168.
8. Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 2010; 126: 2762-2772.
9. Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS et al. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: A method for identifying cancers sensitive to arginine deprivation. Cancer 2004; 100: 826-833.
10. Osunkoya BO, Adler WH, Smith RT. Effect of arginine deficiency on synthesis of DNA and immunoglobulin receptor of Burkitt lymphoma cells. Nature 1970; 227: 398-399.
11. Delage B, Luong P, Maharaj L, O'Riain C, Syed N, Crook T et al. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis. Cell Death Dis 2012; 3: E342.
12. Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA. Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol 2011; 4: 138-146.
13. Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C et al. Pegylated arginase I: A potential therapeutic approach in T-ALL. Blood 2010; 115: 5214-5221.
14. Hsueh EC, Knebel SM, Lo WH, Leung YC, Cheng PN, Hsueh CT. Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol Oncol 2012; 5: 17.
15. Yau T, Cheng PN, Chan P, Chan W, Chen L, Yuen J et al. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma. Invest New Drugs 2013; 31: 99-107.
16. Garcia-Navas R, Munder M, Mollinedo F. Depletion of L-Arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes. Autophagy 2012; 8: 0-19.
17. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspaseindependent apoptosis. Cancer Res 2009; 69: 700-708.
18. Mizushima N, Komatsu M. Autophagy: Renovation of cells and tissues. Cell 2011; 147: 728-741.
19. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
20. Lozy F, Karantza V. Autophagy and cancer cell metabolism. Semin Cell Dev Biol 2012; 23: 395-401.
21. Wirawan E, Vanden Berghe T, Lippens S, Agostinis P, Vandenabeele P. Autophagy: For better or for worse. Cell Res 2012; 22: 43-61.
22. Madeo F, Tavernarakis N, Kroemer G. Can autophagy promote longevity? Nat Cell Biol 2010; 12: 842-846.
23. Shintani T, Klionsky DJ. Autophagy in health and disease: A double-edged sword. Science 2004; 306: 990-995.
24. Savaraj N, You M, Wu C, Wangpaichitr M, Kuo MT, Feun LG. Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med 2010; 10: 405-412.
25. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115: 577-590.
26. Miyazaki K, Takaku H, Umeda M, Fujita T, Huang WD, Kimura T et al. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res 1990; 50: 4522-4527.
27. Shen LJ, Lin WC, Beloussow K, Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett 2003; 191: 165-170.
28. Tsai WB, Aiba I, Lee SY, Feun L, Savaraj N, Kuo MT. Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4. Mol Cancer Ther 2009; 8: 3223-3233.
29. van Rijn J, van den Berg J, Schipper RG, de Jong S, Cuijpers V, Verhofstad AAJ et al. Induction of hyperammonia in irradiated hepatoma cells: A recapitulation and possible explanation of the phenomenon. Brit J Cancer 2004; 91: 150-152.
30. Kuo MT, Savaraj N, Feun LG. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget 2010; 1: 246-251.
31. Dziedzic SA, Caplan AB. Autophagy proteins play cytoprotective and cytocidal roles in leucine starvation-induced cell death in Saccharomyces cerevisiae. Autophagy 2012; 8: 731-738.
32. Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 2009; 16: 1018-1029.
33. Li X, Lu Y, Pan T, Fan Z. Roles of autophagy in cetuximab-mediated cancer therapy against EGFR. Autophagy 2010; 6: 1066-1077.
34. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011; 25: 23-31.
35. Thomé R, Lopes SC, Costa FT, Verinaud L. Chloroquine: Modes of action of an undervalued drug. Immunol Lett 2013; 153: 50-57.
36. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011; 17: 654-666.
37. Huan Y, Xian Z. Expression System for Recombinant Human Arginase I. US patent: US, 2008. 2008/0138858 A1.
38. Chiarini F, Grimaldi C, Ricci F, Tazzari PL, Evangelisti C, Ognibene A et al. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia. Cancer Res 2010; 70: 8097-8107.
39. Zhu XJ, Shi Y, Peng J, Guo CS, Shan NN, Qin P et al. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 2009; 114: 5362-5367.
40. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69: 1553-1560.
41. Shen Y, Yang X, Dong N, Xie X, Bai X, Shi Y. Generation and selection of immunized Fab phage display library against human B cell lymphoma. Cell Res 2007; 17: 650-660.
42. Chan LL, Shen D, Wilkinson AR, Patton W, Lai N, Chan E et al. A novel image-based cytometry method for autophagy detection in living cells. Autophagy 2012; 8: 1371-1382.
43. Li Y, Zhu H, Zeng X, Fan J, Qian X, Wang S et al. Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-beta in human glioma cells. Mol Neurobiol 2013; 47: 1000-1010.